AACR: Exosome-Based miRNA Assay Can Detect Pancreatic Cancer

MONDAY, April 8, 2024 -- An exosome-based liquid biopsy assay can distinguish patients with pancreatic ductal adenocarcinoma (PDAC) from healthy donors (HDs), according to a study presented at the annual meeting of the American Association for...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news